Key facts
- This page summarizes John B. Henneman III's Form 4 filing for SeaSpine Holdings Corp.
- 4 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 09 Jan 2023, 18:19.
John B. Henneman III - 05 Jan 2023 Form 4 Insider Report for SeaSpine Holdings Corp
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 05 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jan 2023, 18:19:39 UTC
- Prior SEC filing
- 01 Aug 2022
- Next SEC filing
- 19 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Benny, Attorney-in-Fact for John B. Henneman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John B. Henneman III filed Form 4 for SeaSpine Holdings Corp on 09 Jan 2023.
Change
- Previous filing in this sequence was filed on 01 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SPNE
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -82,654
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SPNE
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -58,559
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 58,559
- Exercise price
- $15.68
- Footnotes
- F2, F3
SPNE
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -3,858
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,858
- Exercise price
- $17.18
- Footnotes
- F4, F5
SPNE
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -13,920
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,920
- Exercise price
- $9.99
- Footnotes
- F6, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
John B. Henneman III is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 7 footnotes
Footnote F1
Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 34,408 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
Footnote F2
The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter.
Footnote F3
This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,378 shares of Orthofix at a price of $37.67 per share.
Footnote F4
The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016.
Footnote F5
This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,606 shares of Orthofix at a price of $41.27 per share.
Footnote F6
The option vests in four equal installments on each of September 7, 2016, December 7, 2016, March 7, 2017 and June 7, 2017.
Footnote F7
This option was assumed by Orthofix in the merger and replaced with an option to purchase 5,794 shares of Orthofix at a price of $24.00 per share.